Skip to main content

MoneyWorks4Me

Dr. Reddy’s Laboratories submits press release

03 Jul 2019 Evaluate

Dr. Reddy’s Laboratories has informed about submission of a press release on ‘Dr. Reddy's Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (lmL) Single-dose Vial in the US Market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1795.70
Dr. Reddys Labs. 1350.10
Cipla 1371.40
Lupin 1987.10
Zydus Lifesciences 1203.00
View more..